Intended for healthcare professionals

CCBYNC Open access
Research

Milk intake and risk of mortality and fractures in women and men: cohort studies

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6015 (Published 28 October 2014) Cite this as: BMJ 2014;349:g6015

Milk and mortality: The impact of over-activated mTORC1 signalling and unnoticed bovine microRNA uptake

Michaëlsson et al.1 reported that a high intake of milk is associated with higher mortality in two large Swedish cohorts of men and women. They proposed that milk-derived D-galactose may accelerate aging.1 Although their data strongly support life shortening effects of milk consumption the authors ignored milk´s physiological function as a signalling system facilitating postnatal growth.2 Milk´s growth promoting activities will be presented as key mechanisms accelerating age-related diseases that increase mortality. McCay and Crowell3 provided evidence that slowing growth favours longevity. The key modulator of ageing and age-related diseases is the nutrient-sensitive kinase mTORC1 (mechanistic target of rapamycin complex 1).4

Milk´s growth-promoting function is restricted to the postnatal period of lactation. Therefore milk activates the central cellular growth regulator, mTORC1.2 mTORC1 activity is stimulated by essential branched-chain amino acids, glutamine and palmitic acid, major components of milk, which represent milk´s hardware promoting mTORC1-dependent growth. Importantly, commercial cow´s milk delivers abundant virus-like exosome particles (50-100 nm), that transfer bovine microRNAs to the milk consumer.5 Milk microRNAs reach the systemic circulation of the human milk consumer, are taken up by human blood cells and subsequently modify gene expression.6 Bovine milk microRNAs and human microRNAs exhibit substantial sequence homology and apparently represent milk´s software regulating gene translation of the milk recipient. Baier et al.6 estimated that the 245 microRNAs of cow´s milk affect the expression of more than 11,000 human genes.6 A major milk microRNA type is microRNA-217 which suppresses translation of important tumour suppressor proteins such as PTEN and thereby increases mTORC1 signalling and cell cycle progression.8 MicroRNA-21 acts as an oncogene, is overexpressed by cancer cells, and stimulates adipocyte differentiation.9 10 Thus, milk consumption enhances mTORC1 and microRNA-21 signalling, which synergistically accelerate cell proliferation, anabolism as well as adipogenesis. Increased mTORC1 signalling is regarded as the driving force of obesity, diabetes, cancer, and accelerated aging.4 11

Milk consumption in children and adolescents increases body weight.12 13 Mice fed with cow´s milk in comparison to milk-free controls exhibited increased liver and adipose tissue mTORC1-S6K1 activity and developed obesity.14 Milk intake of children has been associated with early onset of menarche,15 a risk factor for the development of type 2 diabetes.16 mTORC1 activates the kinase S6K1, which down-regulates insulin receptor substrate-1, inducing insulin resistance.17 In fact, insulin resistance has been observed in children consuming daily 53 g milk protein in comparison to 53 g meat protein.18
Remarkably, populations with a high (>30%) prevalence of lactose malabsorption (LM) whose milk intake is low have a lower risk of ischaemic heart disease than populations with a LM prevalence under 30% and high milk consumption.19 Epidemiological data support the association between milk consumption and death of coronary heart disease.20 In another large Swedish cohort study, people with lactose intolerance, characterised by low milk and dairy consumption had decreased risks of lung, breast, and ovarian cancers.21

Increased milk intake has been associated with prostate cancer-specific mortality among U.S. male physicians.22 Activated mTORC1 signalling plays a pivotal role in the initiation and progression of prostate cancer.23 24 Notably, milk added to prostate cancer cells in culture increased cancer cell proliferation by 30%.25 Rats with anthracene-induced mammary tumours fed commercial milk doubled tumour mass and numbers in comparison to milk-free controls.26

The age-related neurodegenerative diseases Alzheimer and Parkinson exhibit increased mTORC1-mediated phosphorylation of tau proteins resulting in tau protein dyshomeostasis.27 28 A significant association between milk consumption and Parkinson´s disease has been observed in the Greece EPIC cohort.29 An extensive Chinese meta-analysis confirmed a dose-response relationship with a 17% increased risk of Parkinson´s disease for every 200 g/day increment in milk intake.30 Thus, persistently over-activated mTORC1, milk´s crucial biological function, accelerates aging and the onset of age-related diseases of civilization.31 32 Notably, only the “civilized” countries provide the technical requirements allowing fresh milk consumption.

In contrast, pharmacological inhibition of mTORC1 in animal models prolonged life span and improved cognitive functions in mice models of Alzheimer´s disease.33 34 The anti-diabetic drug metformin, which controls diabetes and decreases the risk of cancer35 has recently been found to prolong life span.36 Importantly, metformin operates as a multifunctional inhibitor of mTORC137 that counteracts milk-mediated activation of mTORC1.

Milk signalling physiologically operates only during the lactation period of mammals with the exception of Neolithic humans. From the perspective of evolutionary biology, milk consumption represents a novel human behaviour that could exert adverse long-term health effects.12 Half a century ago, the antagonistic pleiotropy theory solved the mystery of aging by postulating genes beneficial early in life at the cost of aging.38 Early in life, the mTORC1 pathway drives a developmental program, which persists later in life as an aimless quasi-program of aging and age-related diseases.38 Since the 1950´s, daily milk consumption containing bioactive microRNAs has been introduced into the Western food chain by the implementation of pasteurization and refrigeration technology. From that time on, diseases of civilization increased dramatically. Thus, neither galactose nor lactose intake but daily, lifelong overstimulation of mTORC1 and the intake of bioactive bovine milk microRNAs provide a more reasonable explanation for accelerated aging and increased mortality. Compared to human milk, cow´s milk apparently induces a much higher magnitude of mTORC1 activation as calves duplicate birth weight four times faster than human infants.

Importantly, Michaëlsson et al.1 only observed a higher mortality rate in association with milk but not with the consumption of fermented milk products. Masai, Samburu and Bantu predominantly consume fermented milk19 that may contain reduced amounts of bioactive milk microRNAs. Thus, future studies have to differentiate health outcomes between cooled fresh milk and milk products that still carry bioactive microRNAs versus processed milk/dairy products that do not transfer the gene regulatory software of the bovine mammary gland to the human milk recipient.

1 Michaelsson K, Wolk A, Langenskiöld S, Basu S, Warensjö Lemming E, Melhus H, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ 2014;349:g6015.
2 Melnik BC, John SM, Schmitz G. Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth. Nutr J 2013;12:103.
3 McCay CM, Crowell MF. Prolonging the life span. The Scientific Monthly 1934;39:405-14.
4 Johnson SC, Rabinovitch PS, Kaeberlein M, mTOR is a key modulator of ageing and age-related disease. Nature 2013;493:338-45.
5 Reinhardt TA, Lippolis JD, Nonnecke BJ, Sacco RE. Bovine milk exosome proteome. J Proteomics 2012;75:1486-92.
6 Baier SR, Nguyen C, Xie F, Wood JR, Zempleni J. MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow milk and affect gene expression in peripheral blood mononuclear cells, HEK- 293 kidney cell cultures, and mouse livers. J Nutr 2014;144:1495-500.
7 Chen X, Gao C, Li H, Huang L, Sun Q, Dong Y, et al. Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res 2010;20:1128-37.
8 Becker LE, Li Y. Apoptosis and target genes of miR-21. Chin J Cancer 2011; 30:371-80.
9 Pan X, Wang ZX, Wang R. MicroRNA-21. A nover therapeutic target in human cancer. Cancer Biol Ther 2010;10:1224-32.
10 Kim YJ, Hwang SH, Cho HH, Shin KK, Bae YC, Jung JS. MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues. J Cell Physiol 2012;227:183-93.
11 Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011;12:21-35.
12 Wiley AS. Cow milk consumption, insulin-like growth factor-I, and human biology: a life history approach. Am J Hum Biol 2012;24:130-8.
13 Arnberg K, Mølgaard C, Michaelsen KF, Jensen SM, Trolle E, Larnkjær A. Skim milk, whey, and casein increase body weight and whey and casein increase the plasma C-peptide concentration in overweight adolescents. J Nutr 2012;142:2083-90.
14 Yamin HB, Barnea M, Genzer Y, Chapnik N, Froy O. Long-term commercial cow's milk consumption and its effects on metabolic parameters associated with obesity in young mice. Mol Nutr Food Res 2014;58:1061-8.
15 Wiley AS. Milk intake and total dairy consumption: associations with early menarche in NHANES 1999-2004. PLoS One 2011;6:e14685.
16 Janghorbani M, Mansourian M, Hosseini E. Systematic review and meta-analysis of age at menarche and risk of type 2 diabetes. Acta Diabetol 2014; 51:519-28.
17 Um SH, D´Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metabol 2006;3:393-402.
18 Hoppe C, Mølgaard C, Vaag A, Barkholt V, Michaelsen. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr 2005;59:393-8.
19 Segall JJ. Hypothesis: Is lactose a dietary risk factor for ischaemic heart disease? Int J Epidemiol 2008;37:1204-8.
20 Moss M. Does milk cause coronary heart diesease? J Nutr Environment Med 2002;12:207-16.
21 Ji J, Sundquist J, Sundquist K. Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden. Br J Cancer 2014; Oct 14 [Epub ahead of print].
22 Song Y, Chavarro JE, Cao Y, Qiu W, Mucci L, Sesso HD, et al. Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr 2013;143:189-96.
23 Melnik BC, John SM, Carrera-Bastos P, Cordain L. The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond) 2012;9:74.
24 Edlind MP, Hsieh AC. PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance. Asian J Androl 2014;16:378-86.
25 Tate PL, Bibb R, Larcom LL. Milk stimulates growth of prostate cancer cells in culture. Nutr Cancer 2011;63:1361-6-
26 Qin LQ, Xu JY, Tezuka H, Li J, Arita J, Hoshi K, et al. Consumption of commercial whole and non-fat milk increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Cancer Detect Prev 2007;31:339-43.
27 Tang Z, Bereczki E, Zhang H, Wang S, Li C, Ji X, et al. Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease. J Biol Chem 2013;288:15556-70.
28 Tenreiro S, Eckermann K, Outeiro TF. Protein phosphorylation in neurodegeneration: friend or foe? Front Mol Neurosci 2014;7:42.
29 Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol 2013;28:67-77.
30 Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson's disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol 2014;29:613-9.
31 Cornu M, Albert V, Hall MN. mTOR in aging, metabolism, and cancer. Curr Opin Genet Dev 2013;23:53-62.
32 Oddo S. The role of mTOR signaling in Alzheimer disease. Front Biosci 2012;S4:941-52.
33 Mendelsohn AR, Larrick JW. Dissecting mammalian target of rapamycin to promote longevity. Rejuvenation Res 2012;15:334-7.
34 Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer´s disease. PloS One 2010;5:e9979.
35 Malek M, Aghili R, Emami Z, Khamseh ME. Risk of cancer in diabetes: the effect of metformin. Endocrinology 2013,2013:636927
36 Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, et al. Can people with type 2 diabetes life longer than those without? A comparison of mortality in people initiatd with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obesity Metabol 2014;16:1165-73.
37 Melnik BC, Schmitz G. Metformin: an inhibitor of mTORC1 signaling. J Endocrinol Diabetes Obes 2014;2:1029.
38 Blagosklonny MV. Revisiting the antagonistic peiotropy theory of aging. TOR- driven program and quasi-program. Cell Cycle 2010;9:3151-6.

Competing interests: I have read and understood the BMJ policy on declaration of interests and declare the following interests: none.

Competing interests: No competing interests

11 November 2014
Bodo C. Melnik
Senior Lecturer
University of Osnabrück, Department of Dermatology, Environmental Medicine and Health Theory
Sedanstrasse 115, D-49090 Osnabrück, Germany